120 results on '"Weil M"'
Search Results
2. Combined intravenous and intra-arterial chemotherapy using Cisplatin, Fluorouracil, Mitomycin C and Etoposide in the treatment of hepatic metastasis
3. Ten years of breast preserving management in infiltrative breast cancer : results in 412 patients treated by Neo-Adjuvant chemotherapy and radiation therapy with or without hormonotherapy
4. Results of Cisplatin (CDDP)/Etoposide (VP16)/5-FU and alternatively Adriamycin or Mitomycin C (PEFAM) combination in primary resistant breast cancer and in heavily pre-treated metastatic breast cancer
5. High-dose therapy in breast cancer
6. Technical aspects of adjuvant intraperitoneal chemotherapy
7. Neo-Adjuvant chemotherapy in cervical cancer stage IIB ; PEC + RT vs RT. Preliminary results
8. Role of pathologic response after primary chemoradiotherapy and esophagectomy for predicted T3–4 N0-1 M0 squamous carcinoma of the thoracic esophagus
9. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer
10. Testicular circulatory isolation prevents testicular exposure to doxorubicin in a rat model
11. Preoperative intra-arterial chemotherapy of advanced breast cancer. Response rate as prognostic factor for overall survival
12. Drug sensitivity testing for regional chemotherapy
13. Preoperative 5-Fluorouracil in resectable colorectal cancer. Preliminary results of a prospective randomized trial
14. Double 5-FU modulation with folinic acid and recombinant alfa2b-Interferon : a phase I–II study in metastatic colorectal cancer patients
15. Early results of the British Columbia breast cancer preoperative (Neo-Adjuvant) chemotherapy trial
16. Prognosis of breast cancer by state of the art laboratory techniques
17. Clinical outcome of intraperitoneal hyperthermo-chemotherapy for patients with refractory gastric cancer
18. Cytotoxic or endocrine primary systemic therapy (PST) for operable large primary breast cancer
19. Conservative management of breast cancer by exclusive radiation therapy following Neo-Adjuvant chemotherapy : results in 236 patients with a minimum 5 years follow-up
20. Application of dose intensity to Neo-Adjuvant therapy
21. Neo-Adjuvant chemotherapy in 101 non inflammatory breast cancers : treatment results
22. Multimodality treatment of stage II, III and IV breast cancer with biochemical modulation of 5-FU/Leucovorin and estrogen recruitment
23. Neo-Adjuvant chemotherapy : Epirubicin in invasive bladder cancer ; four-year follow-up
24. Induction chemotherapy with Cisplatin and 5-FU for squamous cell carcinoma of the head and neck. Six years experience at the Nice Cancer Center
25. Preservation of the larynx following Neo-Adjuvant chemotherapy. A preliminary report
26. Neo-Adjuvant chemotherapy for patients with oral and oro-pharyngeal T3/T4 carcinomas
27. Perioperative chemotherapy in hypopharyngeal squamous cell carcinomas (SCC)
28. Treatment of locally advanced head and neck cancer with Neo-Adjuvant Cisplatin (CDDP) and 5-Fluorouracil (5-FU) chemotherapy (CT)
29. Neo-Adjuvant intra-arterial chemotherapy by Cisplatin and 5-FU for squamous cell carcinoma of the oral cavity
30. Efficacy of concomitant chemoradiotherapy in poor prognosis head and neck cancer
31. 5-Fluorouracil modulation in head and neck cancer
32. Neo-Adjuvant Cisplatin, 5-Fluorouracil and high-dose Leucovorin for advanced head and neck cancer : response, toxicity, survival and comparison with historical controls
33. Exclusive chemotherapy in head and neck cancer
34. Regional control after induction chemotherapy for advanced squamous cell carcinoma of the head and neck (SCCHN): a retrospective analysis of 303 patients
35. Multimodality treatment for small cell bronchial carcinomas (SCLC)
36. The impact of molecular genetics on the detection of residual malignant disease
37. Hairy cell leukemia: current treatment strategies
38. Combined modality therapy for stage III non-small cell lung cancer : the University of Chicago experience
39. Phase II pilot study of Ifosfamide-Cisplatine-Etoposide association as Neo-Adjuvant chemotherapy in locally advanced non-small cell lung cancers
40. Faster response and survival advantage with Neo-Adjuvant Cisplatin and 5-Fluorouracil infusion versus Cisplatin and Bleomycin in advanced non-small cell lung cancer
41. High incidence of CNS metastases in long-term survivors (LTS) stage III (T4/N2) non-small cell lung cancer (NSCLC). Patients treated with Neo-Adjuvant chemotherapy
42. Diarylsulfonylureas : new anticancer agents with novel activities, toxicities and mechanism of action
43. Circadian chemotherapy against stage IIIB-IV non-small-cell lung cancer (NSCLC) with 5-Fluorouracil (5-FU), folinic acid (FOL) and cisplatin (CDDP) via a multichannel programmable pump. Preliminary results
44. Issues in multidrug resistance
45. Involvement of the Interleukin 2/Interleukin 2-receptor system in the proliferation of human immature leukemic T cells
46. Phase II study of THP-Adriamycin (Pirarubicin) and DTIC in advanced soft tissue sarcomas
47. Chemotherapy of soft tissue sarcomas with Cyclophosphamid or Ifosfamid, Adriamycin and DTIC (CAD or IAD) preoperatively and in patients with metastatic disease : a non randomized pilot study
48. The combination of Etoposide and Cyclophosphamide as Neo-Adjuvant chemotherapy for osteosarcoma
49. The first Claude Jacquillat Memorial Lecture : Chemotherapy of cancer
50. Two different regimens with ifosfamide as preoperative chemotherapy in children with unresectable rhabdomyosarcoma. A report from the German soft tissue sarcoma study CWS-86 and the Italian rhabdomyosarcoma study ICG-88
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.